Totally implanted central venous access devices inserted by the femoral route: A narrative review and the proposal of a novel approach, the FICC-port
The Journal of Vascular Access · 2025
DOI: 10.1177/11297298241236816 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Vascular Access, 2025. Verfasst von Maria Giuseppina Annetta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Intensive Care, Policlinico Universitario "A.Gemelli," Rome, Lazio, Italy. Hauptthemen laut MEDLINE: Femoral Vein, Catheterization, Central Venous, Catheters, Indwelling, Central Venous Catheters. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
Femoral ports are used in patients with indication to a totally implanted venous access device but with contraindication to chest-ports and brachial ports because of obstruction of the superior vena cava. In the last three decades, femoral ports have been implanted almost exclusively by cannulation of the common femoral vein at the groin, while the position of the tip has been assessed by X-ray.
Methods
We report our experience with a new approach to femoral ports, which includes recent methods and techniques developed in the last few years. These novel femoral ports, which we call “FICC-ports,” are characterized by (a) long femoral 5 Fr polyurethane catheter inserted by ultrasound-guided puncture of the superficial femoral vein at mid-thigh; (b) intraprocedural location of the tip in the sub-diaphragmatic inferior vena cava, using ultrasound visualization by the transhepatic and/or the subcostal view; (c) low-profile or very low-profile reservoir implanted above the quadriceps muscle, at mid-thigh.
Results
In the last 3 years, we have implanted 47 FICC-ports in young adults with mediastinal lymphoma compressing the superior vena cava. We had no immediate/early complication, and only three late complications (one kinking of the catheter in the subcutaneous tissue; one tip migration with secondary venous thrombosis; one persistent withdrawal occlusion due to fibroblastic sleeve).
Conclusion
If there is indication to a femoral port, the implantation of a “FICC-port”—as described above—is to be strongly considered in terms of safety, effectiveness, and cost-effectiveness: no immediate-early complications, minimal late complications, no X-ray exposure, low invasiveness, low cost.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesia and Intensive Care, Policlinico Universitario "A.Gemelli," Rome, Lazio, Italy.
- Department of Hematology, Policlinico Universitario "A.Gemelli," Rome, Lazio, Italy.
- Izasa Medical, Barcelona, Spain.
- Department of Surgery, Policlinico Universitario "A.Gemelli," Rome, Lazio, Italy.
ORCID-Profile: Maria Giuseppina Annetta, Mauro Pittiruti
Zitieren
APA
Annetta, M. G., Marche, B., Ortiz Miluy, G., & Pittiruti, M. (2025). Totally implanted central venous access devices inserted by the femoral route: A narrative review and the proposal of a novel approach, the FICC-port. The Journal of Vascular Access. https://doi.org/10.1177/11297298241236816
Vancouver
Annetta MG, Marche B, Ortiz Miluy G, Pittiruti M. Totally implanted central venous access devices inserted by the femoral route: A narrative review and the proposal of a novel approach, the FICC-port. The Journal of Vascular Access. 2025. doi:10.1177/11297298241236816
BibTeX
@article{Annetta2025,
author = {Annetta, Maria Giuseppina and Marche, Bruno and Ortiz Miluy, Gloria and Pittiruti, Mauro},
title = {Totally implanted central venous access devices inserted by the femoral route: A narrative review and the proposal of a novel approach, the FICC-port},
journal = {The Journal of Vascular Access},
year = {2025},
doi = {10.1177/11297298241236816}
}
EUVIMED